Showing results (931-940 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|March 23, 2023
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort StudyZhe Huang, Huan Yan, Liang Zeng, et al.
JCO Precision Oncology|November 12, 2022
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal CancerSarah E Coughlin, Brandie Heald, Dana Farengo Clark, et al.
JCO Precision Oncology|December 10, 2025
Expression of Poliovirus Receptor, the Ligand of TIGIT, Associated With Immune-Cold Tumor Microenvironment in Hepatocellular CarcinomaLi-Chun Lu, Yi-Hsuan Lee, Yu-Yun Shao, et al.
JCO Precision Oncology|January 23, 2026
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 InhibitorsThomas N O'Connor, Emily Schultz, Sheheryar Kabraji, et al.
JCO Precision Oncology|January 21, 2026
Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern Unites StatesJenny O'Brien, Ryne C Ramaker, Ashley Moyer, et al.
JCO Precision Oncology|January 14, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO TrialFélix Blanc-Durand, Benoit You, Yahia Adnani, et al.
JCO Precision Oncology|November 20, 2025
Decision Tables for Calibration-Free Odds Design in Phase I Clinical TrialsNinghao Zhang, Guosheng Yin
JCO Precision Oncology|November 14, 2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast CancersJulia Foldi, Kaitlyn Xiong, Matthew Liu, et al.
JCO Precision Oncology|November 14, 2025
Evaluation of Raw Cell-Free DNA Sequences for Gastric Cancer DetectionYe Tian, Yichen Yang, Jilei Liu, et al.
JCO Precision Oncology|December 22, 2025
Concordance of Oncotype DX Breast Recurrence Score Assay Results Between Paired Core Needle Biopsy and Surgical Excision Specimens in Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative, Early-Stage Breast CancerAziza Nassar, Jodi Carter, Paige Innis, et al.
Pageof 140